the 2nd Viral Vector Process Development & Manufacturing Summit is your must-attend meeting in 2024. Secure your place and get your burning questions answered to enhance process intensification ...

Reagent kits can make the transfection process reliable, scalable, cost-effective and standardized — key considerations for viral vector manufacturing. “Without a partner with a deep ...

They engineered an adenoviral vector to include a repressor protein ... other advantages over alternative ‘helper-free’ rAAV manufacturing systems. “For all the serotypes tested, we ...

How to design and launch a successful Clinical Trial Manufacturing.

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

to support the development of an intensified manufacturing process for recombinant adeno-associated virus (AAV) vectors. This ...

Novartis invested €40 million (US$43 million) into the facility, which is the company’s first specialized viral vector manufacturing facility in ... and efficiency at all stages of the production ...